의료기기 제조 장비 세계 시장 : 유형별, 최종사용자별, 용도별, 지역별 - 예측(-2030년)

The medical device manufacturing equipment (by production) market is projected to reach USD 27.80 billion by 2030 from USD 19.24 billion in 2025, at a CAGR of 7.6% during the forecast period.

The medical device manufacturing equipment market is driven by technological advancements in automation, robotics, and precision machining, and increasing demand for high-quality, compliant devices. Growth is restrained by high capital costs, complex regulatory requirements, and supply chain vulnerabilities. Opportunities exist in emerging markets, where investments in local manufacturing are rising, and in customized and minimally invasive device production, supported by 3D printing and advanced materials. Digital integration, like IoT and AI, further enhances production efficiency and scalability.

Based on material processing equipment type, the additive manufacturing/3D printing systems are expected to witness the highest growth rate during the forecast period due to their ability to produce complex, customized devices rapidly, reduce material waste, shorten production cycles, and support prototyping and small-batch production. Their flexibility, precision, and compatibility with advanced materials make them highly valuable for minimally invasive and patient-specific medical devices, driving widespread adoption globally.

Based on end user, contract manufacturing organizations are expected to have the highest growth rate during the forecast year. This is driven by the ability to provide specialized, cost-effective production solutions without heavy capital investment. They offer scalable manufacturing, regulatory compliance expertise, and access to advanced technologies, enabling medical device companies to focus on R&D and marketing while ensuring efficient, high-quality device production across global markets.

Asia Pacific is projected to exhibit the highest growth rate during the forecast year. The surge is driven by rapidly expanding healthcare infrastructure, rising government investments, and increasing medical device production. Countries like China, India, and Japan are adopting advanced manufacturing technologies, including automation and 3D printing. Additionally, low labor costs, favorable regulatory reforms, and growing demand for patient-specific devices are driving the region's high market growth rate.

A breakdown of the primary participants (supply-side) for the medical device manufacturing equipment (by production) market referred to in this report is provided below:

• By Company Type: Tier 1: 34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the medical device manufacturing equipment (by production) market are STERIS (US), Nordson Corporation (US), ENGEL (Austria), Zeiss Group (Germany), Multivac (Germany), Coherent Corp. (US), KUKA AG (Germany), ABB (Switzerland), TRUMPF (Germany), OC Oerlikon Management AG (Switzerland), Arburg (Germany), Stratasys Ltd (US), Plasmatreat (Germany), Nikon Corporation (Japan), and Mitutoyo Corporation (Japan), among others.

Research Coverage

The report evaluates the medical device manufacturing equipment (by production) market and estimates the market size and future growth potential of this market based on various segments including equipment type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall, the medical device manufacturing equipment (by production) market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

• Analysis of key drivers (technological advancements in manufacturing, increased healthcare expenditure, and rising production demand), restraints (supply chain vulnerabilities and stringent regulatory requirements), opportunities (customization and personalization and adoption of digital health solutions), and challenges (trade tariffs and import restrictions)
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global medical device manufacturing equipment (by production) market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by equipment type, application, end user, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global medical device manufacturing equipment (by production) market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global medical device manufacturing equipment (by production) market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY USED
• 1.5 STAKEHOLDERS
• 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET OVERVIEW
• 4.2 ASIA PACIFIC: MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, BY TYPE AND COUNTRY (2024)
• 4.3 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, REGIONAL MIX, 2023-2030
• 4.5 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Technological advancements in manufacturing
    • 5.2.1.2 Increased healthcare expenditure
    • 5.2.1.3 Rising production demand
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Supply chain vulnerabilities
    • 5.2.2.2 Stringent regulatory requirements
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Customization and personalization
    • 5.2.3.2 Adoption of digital health solutions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Trade tariffs and import restrictions
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024
  • 5.4.2 AVERAGE SELLING PRICE TREND OF INJECTION MOLDING MACHINES, BY REGION, 2022-2024
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT & FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Injection molding systems
    • 5.9.1.2 Additive manufacturing (3D printing)
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Metrology & inspection equipment
    • 5.9.2.2 Cleanroom & contamination control systems
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Industrial robotics & automation
    • 5.9.3.2 Industrial IoT (IIoT) & AI analytics
• 5.10 INDUSTRY TRENDS
  • 5.10.1 SHIFT TOWARD SMART MANUFACTURING & INDUSTRY 4.0 INTEGRATION
  • 5.10.2 RISING DEMAND FOR CUSTOMIZATION AND ADDITIVE MANUFACTURING
• 5.11 PATENT ANALYSIS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT DATA (HS CODE 8477)
  • 5.12.2 EXPORT DATA (HS CODE 8477)
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 CASE STUDY 1: MMT/SOMEX AUTOMATION - MANDREL REMOVAL/INSERTION FOR CATHETER SHAFTS
  • 5.14.2 CASE STUDY 2: HAHN AUTOMATION GROUP - AUTOMATED COILING FOR VASCULAR DEVICE OEM
  • 5.14.3 CASE STUDY 3: AMS MACHINES - ADHESIVE DISPENSE AND UV CURE AUTOMATION FOR WEARABLE INJECTOR OEM
• 5.15 REGULATORY ANALYSIS
  • 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.2 REGULATORY FRAMEWORK
    • 5.15.2.1 North America
      • 5.15.2.1.1 US
      • 5.15.2.1.2 Canada
    • 5.15.2.2 Europe
      • 5.15.2.2.1 Germany
      • 5.15.2.2.2 France
      • 5.15.2.2.3 UK
    • 5.15.2.3 Asia Pacific
      • 5.15.2.3.1 India
      • 5.15.2.3.2 China
      • 5.15.2.3.3 Japan
    • 5.15.2.4 Latin America
      • 5.15.2.4.1 Brazil
      • 5.15.2.4.2 Mexico
    • 5.15.2.5 Middle East & Africa
      • 5.15.2.5.1 Middle East
      • 5.15.2.5.2 Africa
• 5.16 PORTER'S FIVE FORCES ANALYSIS
  • 5.16.1 BARGAINING POWER OF SUPPLIERS
  • 5.16.2 BARGAINING POWER OF BUYERS
  • 5.16.3 THREAT OF NEW ENTRANTS
  • 5.16.4 THREAT OF SUBSTITUTES
  • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 IMPACT OF AI/GENERATIVE AI ON MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET
  • 5.18.1 AI USE CASES
  • 5.18.2 KEY COMPANIES IMPLEMENTING AI
  • 5.18.3 FUTURE OF AI/GEN AI
• 5.19 IMPACT OF 2025 US TARIFFS ON MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET
  • 5.19.1 KEY TARIFF RATES
  • 5.19.2 PRICE IMPACT ANALYSIS
  • 5.19.3 KEY IMPACT ON COUNTRY/REGION
    • 5.19.3.1 US
    • 5.19.3.2 Europe
    • 5.19.3.3 Asia Pacific
  • 5.19.4 IMPACT ON END-USE INDUSTRIES

6 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 MATERIAL PROCESSING EQUIPMENT
  • 6.2.1 INJECTION MOLDING MACHINES
    • 6.2.1.1 Growing need for high-volume disposables and diagnostics to drive precision molding capacity
  • 6.2.2 LASER CUTTING & WELDING SYSTEMS
    • 6.2.2.1 UDI compliance to accelerates adoption of corrosion-resistant, permanent laser black marking
  • 6.2.3 ADDITIVE MANUFACTURING/3D PRINTING SYSTEMS
    • 6.2.3.1 Personalization and complexity advantages to shift AM from prototyping to production
  • 6.2.4 OTHER MATERIAL PROCESSING EQUIPMENT
• 6.3 ASSEMBLY & AUTOMATION SYSTEMS
  • 6.3.1 ROBOTIC ASSEMBLY LINES
    • 6.3.1.1 Ability of cobots with AI vision to elevate yield and reduce contamination risk to drive adoption
  • 6.3.2 PICK & PLACE ROBOTICS
    • 6.3.2.1 Ability of SCARA and delta robots to standardize repeatable handling across ISO cleanrooms to boost demand
  • 6.3.3 DISPENSING & GLUING SYSTEMS
    • 6.3.3.1 Growing demand for miniaturized devices to drive need for precise, biocompatible bonding with closed-loop control
  • 6.3.4 ULTRASONIC WELDING & BONDING SYSTEMS
    • 6.3.4.1 ISO 11607 validation to drive demand for ultrasonic sealing across sterile packaging lines
• 6.4 SURFACE TREATMENT & COATING EQUIPMENT
  • 6.4.1 PLASMA TREATMENT SYSTEMS
    • 6.4.1.1 Solvent-free surface activation to boost adhesion, yield, and sustainability metrics
  • 6.4.2 ELECTROPOLISHING & ANODIZING SYSTEMS
    • 6.4.2.1 Demand for corrosion-resistant, ultraclean finishes to drive standardized electropolishing investments
  • 6.4.3 COATING SYSTEMS
    • 6.4.3.1 Infection prevention and performance gains to fuel validated medical coating investments
• 6.5 TESTING & INSPECTION SYSTEMS
  • 6.5.1 OPTICAL INSPECTION SYSTEMS
    • 6.5.1.1 Growing adoption of AI-driven 2D/3D machine vision to support growth
  • 6.5.2 LEAK & PRESSURE TESTERS
    • 6.5.2.1 ISO 11607 compliance mandates to drive demand for robust, automated leak and seal testing
  • 6.5.3 METROLOGY EQUIPMENT
    • 6.5.3.1 ISO 13485 traceability to elevate advanced metrology investments
  • 6.5.4 ELECTRICAL & FUNCTIONAL TESTERS
    • 6.5.4.1 IEC 60601 compliance requirements to drive demand for automated electrical and functional testing
• 6.6 STERILIZATION & CLEANING EQUIPMENT
  • 6.6.1 STEAM STERILIZERS
    • 6.6.1.1 Infection prevention priorities to drive upgrades to networked, efficient autoclaves
  • 6.6.2 HYDROGEN PEROXIDE PLASMA SYSTEMS
    • 6.6.2.1 EtO emission pressures to accelerate adoption of VHP/H2O2 plasma systems
  • 6.6.3 ETHYLENE OXIDE SYSTEMS
    • 6.6.3.1 Irreplaceable material compatibility to preserve EtO demand despite tighter regulations
  • 6.6.4 ULTRASONIC CLEANING SYSTEMS
    • 6.6.4.1 ISO-driven validations to accelerate adoption of automated, aqueous ultrasonic cleaning
• 6.7 PACKAGING & LABELING EQUIPMENT
  • 6.7.1 BLISTER PACKAGING MACHINES
    • 6.7.1.1 Need for unit dose, tamper evident formats to drive blister capacity investments globally
  • 6.7.2 FORM-FILL-SEAL (FFS) SYSTEMS
    • 6.7.2.1 Inline seal monitoring to accelerate validations and time to market
  • 6.7.3 LABELING & CODING SYSTEMS
    • 6.7.3.1 UDI deadlines to drive serialization, printing, and vision verified coding investments
  • 6.7.4 OTHER PACKAGING & LABELING EQUIPMENT
• 6.8 CLEANROOM & ENVIRONMENTAL SYSTEMS
  • 6.8.1 CLEANROOM INFRASTRUCTURE
    • 6.8.1.1 ISO 14644 compliance to drive demand for HVAC, zoning, and continuous environmental monitoring
  • 6.8.2 HVAC, HUMIDITY, AND ESD PROTECTION SYSTEMS
    • 6.8.2.1 Annex 1 and ISO 14644 to elevate HVAC control and monitoring
  • 6.8.3 CONTAMINATION CONTROL SYSTEMS
    • 6.8.3.1 Annex 1 mandates to boost contamination control investments

7 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, BY END USER

• 7.1 INTRODUCTION
• 7.2 MEDICAL DEVICE OEMS
  • 7.2.1 ABILITY OF OEMS TO DRIVE INNOVATION AND ENSURE REGULATORY COMPLIANCE TO DRIVE MARKET GROWTH
• 7.3 CONTRACT MANUFACTURING ORGANIZATIONS
  • 7.3.1 PIVOTAL ROLE PLAYED BY CMOS IN DRIVING EQUIPMENT DEMAND TO SUPPORT MARKET GROWTH
• 7.4 RESEARCH & ACADEMIC PROTOTYPING CENTERS
  • 7.4.1 ABILITY TO MITIGATE RISKS AND SPEED UP TRANSFER OF CONCEPTS TO BOOST GROWTH

8 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CONSUMABLES & DISPOSABLES
  • 8.2.1 RISING SINGLE-USE ADOPTION TO MEET STERILITY, COMPLIANCE, AND THROUGHPUT REQUIREMENTS TO DRIVE MARKET
• 8.3 SURGICAL INSTRUMENTS
  • 8.3.1 GROWTH IN MINIMALLY INVASIVE PROCEDURES TO BOOST PRECISION MACHINING INVESTMENTS AND DRIVE MARKET GROWTH
• 8.4 IMPLANTS
  • 8.4.1 AGING DEMOGRAPHICS AND EXPANDING ORTHOPEDIC VOLUMES TO DRIVE MARKET
• 8.5 DIAGNOSTIC & THERAPEUTIC DEVICES
  • 8.5.1 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE HIGH-SPEED CARTRIDGE MOLDING AND SEALING CAPACITY
• 8.6 DRUG DELIVERY DEVICES
  • 8.6.1 PREFILLED SYRINGE ADOPTION TO ACCELERATE HIGH-SPEED ASSEMBLY AND INSPECTION
• 8.7 OTHER DEVICES

9 MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 EUROPE
  • 9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.2.2 GERMANY
    • 9.2.2.1 Germany's engineering expertise and EU MDR compliance to drive adoption of advanced medical device production equipment
  • 9.2.3 FRANCE
    • 9.2.3.1 Rising demand for implants and disposables to fuel French investment in molding, coating, and automation systems
  • 9.2.4 UK
    • 9.2.4.1 Regulatory compliance and export competitiveness to drive adoption of automation, packaging, and inspection equipment
  • 9.2.5 ITALY
    • 9.2.5.1 Italy's packaging leadership and EU MDR compliance to drive strong adoption of medical device manufacturing equipment
  • 9.2.6 SPAIN
    • 9.2.6.1 Spain's regulatory compliance and growing CMO base to accelerate adoption of medical device production equipment
  • 9.2.7 REST OF EUROPE
• 9.3 NORTH AMERICA
  • 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.3.2 US
    • 9.3.2.1 FDA compliance and reshoring strategies to accelerate adoption of automation, sterilization, and inspection systems
  • 9.3.3 CANADA
    • 9.3.3.1 Growing modernization of production facilities with cleanroom equipment to enhance export competitiveness
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Japan's robotics and precision engineering strengths to drive accelerated adoption of medical device production equipment
  • 9.4.3 CHINA
    • 9.4.3.1 Government policies and domestic demand to fuel China's adoption of molding, sterilization, and automation equipment
  • 9.4.4 INDIA
    • 9.4.4.1 Government incentives and medical device parks to accelerate adoption of molding, sterilization, and automation equipment
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Regulatory rigor and Industry 4.0 integration to drive South Korea's rapid adoption of medical device production equipment
  • 9.4.6 AUSTRALIA
    • 9.4.6.1 Australia's innovation clusters and strict TGA compliance to drive adoption of advanced medical device production equipment
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 ANVISA compliance and domestic demand to drive Brazil's adoption of advanced medical device production equipment
  • 9.5.3 MEXICO
    • 9.5.3.1 USMCA integration and FDA compliance to accelerate Mexico's adoption of advanced medical device manufacturing equipment
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 HEALTHCARE INDUSTRIALIZATION PROGRAMS TO ACCELERATE ADOPTION OF CLEANROOM, INSPECTION, AND LABELING TECHNOLOGIES
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 RISING LOCAL MANUFACTURING CAPACITY TO FUEL DEMAND FOR STERILIZATION, MOLDING, AND PACKAGING SYSTEMS
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL DEVICE MANUFACTURING EQUIPMENT MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Equipment footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of startups/SMEs
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
  • 10.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ABB
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 STERIS
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 ZEISS GROUP
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 TRUMPF
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 NORDSON CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 ENGEL
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 HUSKY INJECTION MOLDING SYSTEMS LTD.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 EMERSON
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 COHERENT CORP.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
  • 11.1.10 OC OERLIKON MANAGEMENT AG
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Expansions
  • 11.1.11 NIKON CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
  • 11.1.12 DURR GROUP
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 MULTIVAC
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 MIKRON
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 STRATASYS LTD.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 BORCHE NORTH AMERICA INC.
  • 11.2.2 R.P. INJECTION SRL
  • 11.2.3 LASERAX
  • 11.2.4 LITHIUM LASERS SRL
  • 11.2.5 AXIAL3D
  • 11.2.6 MOLD HOTRUNNER SOLUTIONS LTD.
  • 11.2.7 ATLAS ENVIRONMENTS, LTD.
  • 11.2.8 BERKSHIRE CORPORATION
  • 11.2.9 CLEAN ROOMS INTERNATIONAL, INC.
  • 11.2.10 CLEAN AIR TECHNOLOGY, INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS